Introduction
Merck/Affymetrix mouse 1.0 custom arrays monitoring 38384 individual transcripts 111 (25,846 Entrez genes) were used. A Custom Definition File is available in GEO database 112 (http://www.ncbi.nlm.nih.gov/geo/GPL9734). NCBI build 37 mapping definitions 113 matched probesets in the array with transcripts (7). Raw intensity was normalized using 114 the RMA algorithm (24). Prefiltering removed transcripts not detected (marked as 115 "absent" by using the MAS5 algorithm with p>0.05) in 50% or more of replicates in all 116 treatment groups, which were not considered further (21). ANOVA (p<0.05) between 117 BPH and BPN, or between BPL and BPN, identified differentially expressed genes (the 118 "gene signature"). 1.2 fold change threshold (BPH vs. BPN, or BPL vs. BPN) of the in 119 silico combined biological replicates selected robust changes in gene expression. In 120 addition, for liver, heart and aorta gene expression, changes with opposite directionality 121 in BPH and BPL were selected. False Discovery Rate (FDR) was assessed by permuting 122 100 times the labels in each dataset prior to any gene filtering, calculating the size of the 123 signature in each permutation, and averaging the results to determine the level of noise. 124 FDR is the ratio between the noise and the size of each signature in percent units. Raw 125 data is available in GEO (GSE19817). Kidney gene expression from Clcn5 KO mice 126 (GSE10162) was analyzed in the same way. Only transcripts present in both Affymetrix 127 430 2.0 and Merck/Affymetrix mouse 1.0 were compared. 128 Enrichment for biological processes was performed by comparing each gene 129 signature against the public gene collections Gene Ontology, KEGG, Swissprot and 130
Panther families. Enrichment P values (hypergeometric distribution) were corrected for 131 multiple testing by using Bonferroni correction. Pathway analysis was performed using 132 gene signatures was performed by using NextBio libraries (NextBio). Kidney Genetics 134
Bayesian networks (6; 29) were built from two mouse F2 intercrosses (C57BL/6J x A/J, 135 and C57BL/6 ob/ob x BTBR ob/ob, manuscript submitted), which generated six 136 independent networks (male, female and combined for each cross). The total number of 137 nodes and edges is 15326 and 35343, respectively. 138
Transcription factor binding site enrichment 139
We used the program MOTIFCLASS from the package CREAD (43). Position 140 weight matrices representing transcription factor binding motifs were obtained from 141
Transfac version 8.2 (31) and Jaspar version 3.0 (49). Promoter sequences were obtained 142 from mouse genome version MM9 and gene annotation from UCSC genome browser. 143
Promoters were defined as 1Kb upstream to 1Kb downstream of transcriptional start site 144 for every annotated transcript. A background set of promoters was generated by 145 randomly selecting 500 promoters from all other mouse promoters that had a similar base 146 composition (±1%) and presence/absence of CpG islands as the foreground sequences. 147 MOTIFCLASS operates as a classifier. Using the foreground and background sequences, 148 it aims to identify those position weight matrices that best classify the promoters into 149 foreground and background. MOTIFCLASS was employed with 10,000 random 150
permutations to obtain a p-value and reported matrices with a specificity larger than 0.5. 151
Results

152
Global variation of gene expression 153 phenotype by looking for genes coregulated in all analyzed tissues in either BPH or BPL 155 strains. mRNA levels for these genes move in the same direction in all tissues in BPH or 156 BPL strains when compared to the BPN baseline (for example upregulated in BPH vs. 157 BPN in all tissues). We found 222 transcripts regulated more than 20% in all tissues 158 (False Discovery Rate (FDR) 0.6%, Figure 1 and Supplementary Table S1 ) and several of 159 them have been previously implicated in hypertension. For example, natriuretic peptide 160 receptor A/guanylate cyclase A (Npr1) is upregulated in BPH mice vs. BPN mice in all 161 tissues, ranging from +1.5 fold in kidney up to +5 fold in aorta (Supplementary Table  162 S1); the chemokine receptor CCR5 exhibits reduced expression in all tissues in BPH 163 mice; Cyp2J2 expression is increased in all tissues in the BPH mice. 164
Of the 222 genes regulated in all tissues in association with blood pressure phenotype 165 only two change in opposite direction in BPH and BPL when compared to BPN: Pcdh17, 166 a protocadherin, and NM_001012326, a transcript with unknown function 167 (Supplementary Figure S1) . We investigated if any of the gene clusters in Figure 1 are 168 enriched for specific biological processes, but found none (data not shown). Next, we 169 investigated whether genes in these clusters are enriched in regulatory motifs, like 170 transcription factor binding sites or miRNA seed matches. We found no enrichment for 171 miRNA seed region matches within the 3'UTR of these transcripts, but we did find 172 enrichment for binding sites of several transcription factors (Supplementary Table S2) . 173
The most prominent one is serum response factor (SRF), whose binding sites are 174 overrepresented in the promoters of genes in cluster four in figure 1 (Supplementary  175   Table S2 ). 176 expression datasets by using Nextbio, a database containing results from all published 178 expression studies. The BPH/BPL signature common for all tissues overlaps significantly 179 (P<10e-8) with the Clcn5 (a chloride/proton exchanger) knock-out mouse kidney 180 signature (GSE10162 in GEO)(51). In order to investigate further the connection between 181 BPH mice and Clcn5 KO mice, we downloaded the original array data from Wright et 182 al(51), and compared the gene expression patterns in kidneys of BPH and Clcn5 mice. 183 307 transcripts are co-regulated with at least 1.2 fold change in these strains, and move in 184 the opposite direction in BPL mice (FDR 10%, Supplementary Figure S2 and 185 Table S4 ). Genes upregulated in BPL mice are enriched for 213 "secreted proteins" (Supplementary Table S9 ). Genes upregulated in BPH mice are 214 enriched for "cell motion", "extracellular space" and "cytoskeleton families" 215 (Supplementary Table S9 ). Ingenuity Pathway Analysis confirmed the enrichment for 216 these biological processes (data not shown). 217
Supplementary
Heart 218 972 transcripts show opposite regulation in heart (FDR 1.3%, Supplementary Figure  219 S3A, Supplementary Table S5 ). Among them, the PPARγ regulated genes Ucp1, Pck1, 220
Angptl4, and adiponectin are upregulated in the heart of BPL mice (Supplementary (Table 1) . 246
To validate the biological significance of the patterns of gene expression changes we 247 detected by microarray, we compared the set of genes contained in the kidney signature 248 with a set of genes obtained by searching PubMed with the words "hypertension" and 249 "blood pressure". Of the 268 genes identified as candidate genes related to blood 250 pressure regulation by the PubMed search, 42 were found in the kidney signature set and 251 eight of them have been found genetically linked to blood pressure elevation in humans 252 according to the OMIM database (Supplementary Table S12) . 253
Gene regulatory networks in the kidney 254
Gene expression analysis alone cannot be used to determine whether the expression 255 The hypertensive (BPH), normotensive (BPN) and hypotensive (BPL) mouse strains 292 were developed from a selection program based solely on blood pressure levels (39). The 293 BPH mice mimic human hypertension with elevated blood pressure, and at 20 weeks they 294 exhibit co-morbidities such as increased heart rate, increased kidney and heart size, and 295 early mortality (41) . A previous profiling study of the adrenal glands from BPH mice 296 identified common mechanisms of blood pressure elevation with that of SHR rats (16) 297 and wide-spread alterations in patterns of gene expression in diverse systems including 298 sympathetic, vasoconstrictor/vasodilator, carbohydrate metabolism or oxidative stress 299 (15). To date, no profiling study focusing on the kidney, liver, heart and aorta from 300 BPH/BPL mice strains has been reported. These organs are central regulators of blood 301 pressure, so an analysis of differentially expressed genes in them should lead to improved 302 understanding of the regulation of blood pressure and to the identification of potential 303 gene targets for pharmacological intervention. With these goals in mind, we characterized 304 these mouse strains at the level of gene expression: we determined the set of genes 305 differentially expressed (gene signatures) in BPH and BPL mice, identifying gene 306 changes in common among the different tissues as well as specific for each analyzed 307 organ. At 12 weeks of age there are no obvious phonotypical pathologies (enlarged 308 organs or increased mortality) beyond changes in blood pressure. We used arrays with 309 twice the number of transcripts than the previous study and improved mapping 310 annotations (7; 15). results from interactions between very diverse molecular pathways across body tissues. In 356 heart, "fatty acid oxidation" and "mitochondrion" gene families are enriched in the blood 357 pressure signature, and some of the genes present in these families are PPARγ regulated 358 genes (PGC1α, Ucp1, Angptl4, Pck1 and adiponectin). All these genes are upregulated inthe heart of BPL mice and concomitantly downregulated in heart of BPH mice. PPARγ 360 itself is also differentially expressed in both mice strains (up 24% in BPL and down 20% 361 in BPH). This suggests that certain metabolic functions in heart could have an impact on 362 blood pressure, which is further supported by the finding that PPARγ agonists lower 363 blood pressure (36). Since PPARγ regulates expression of renin (46), our findings suggest 364 that the PPARγ-renin-angiotensin receptor system may have important roles in heart 365 function. 366
A second gene family showing coregulation in heart is a group of "cytoskeletal 367
proteins", upregulated in BPH and downregulated in BPL mice when compared to BPN 368 mice. This gene family includes genes like Kif1b, Mapre1, Arpc2, the muscle proteins 369
Tmod4 and Myot, and the Wiskott-Aldrich syndrome proteins Was and Wasf2. All these 370 proteins participate in several aspects of cytoskeleton function, and may have a role in 371 heart muscle contraction, which directly impacts blood pressure regulation. In aorta, 372 genes with increased expression in BPH (and low expression in BPL) are enriched for 373 "cell motion", "extracellular space" and "cytoskeleton families" suggesting a link 374 between increased blood pressure in BPH mice and changes in arterial contractility and 375 stiffness. These are some examples of how gene expression profiling in model organisms 376 can be used to infer relationships between the molecular pathways differentially 377 expressed and the phenotype of interest. 378
An interesting finding is the similarity between Clcn5 KO and BPH gene expression 379 signatures in kidney, with a statistically significant overlap in gene expression changes 380 between these strains that is reversed in BPL mice. Clcn5 is a kidney chloride/proton 381 exchanger and the knock-out mouse mimics the phenotype of Dent disease, which isglycosuria, all of them attributed to proximal tubule malfunction (51). Genes like 384
Uromodulin, Nephrosis1 and Nephrosis2, known markers of renal function, are among 385 the genes that are upregulated in both BPH and Clcn5 KO, and downregulated in BPL 386 mice, so these genes or others in the same pathways could be potential new targets for 387 pharmacological intervention. Our results suggest common molecular mechanisms 388 between chloride homeostasis and blood pressure regulation. Interestingly, Clcn5 is 389 upregulated in kidney of BPH mice, so it is possible that this could be driven by a 390 compensatory mechanism as well. 
